Additionally, high ASPH expression has been linked to tumor recurrence, such as in retroperitoneal liposarcoma (RPLS), where it serves as an independent risk factor for recurrence (29), and has been identified as a potential target regulating tumor cell migration and invasion (30). The gene discussed is ASPH; the disease is Posterior Leukoencephalopathy Syndrome.